Safety and Immunogenicity of Zoster Vaccine (ZOSTAVAX™) Made With an Alternative Manufacturing Process (AMP) (V211-042 AM1)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
This study will determine whether ZOSTAVAX™ made with an alternative manufacturing process \[ZOSTAVAX™ (AMP)\] is well tolerated and immunogenic, and has a comparable immune response to ZOSTAVAX™.
Epistemonikos ID: c4f87233dab15c7e0f35a8f982a94e53d0830045
First added on: May 10, 2024